Nivolumab-induced polyarthritis

BMJ Case Rep. 2017 Dec 2;2017:bcr2017223387. doi: 10.1136/bcr-2017-223387.
No abstract available

Keywords: drugs: musculoskeletal and joint diseases; musculoskeletal syndromes.

Publication types

  • Case Reports

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal / adverse effects
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / adverse effects
  • Bursitis / chemically induced*
  • Bursitis / diagnostic imaging
  • Bursitis / drug therapy
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Female
  • Humans
  • Lymphatic Metastasis
  • Middle Aged
  • Nivolumab
  • Positron Emission Tomography Computed Tomography*
  • Prednisone / therapeutic use
  • Shoulder Joint / diagnostic imaging*
  • Shoulder Joint / pathology
  • Tenosynovitis / chemically induced
  • Tenosynovitis / diagnostic imaging*
  • Tenosynovitis / pathology
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Nivolumab
  • Prednisone